Taysha Gene Therapies, Inc. (TSHA)
6.015
-0.18
(-2.98%)
USD |
NASDAQ |
Aug 26, 16:00
6.14
+0.12
(+2.08%)
After-Hours: 20:00
Taysha Gene Therapies Price : 6.015 for Aug. 26, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 5.99 | 6.27 | 5.99 | 6.20 | 1.691M |
| Aug 24, 2026 | 6.02 | 6.075 | 5.825 | 5.97 | 2.590M |
| Aug 21, 2026 | 6.18 | 6.24 | 6.015 | 6.09 | 2.831M |
| Aug 20, 2026 | 6.04 | 6.30 | 5.92 | 6.11 | 3.397M |
| Aug 19, 2026 | 6.40 | 6.52 | 6.29 | 6.43 | 4.280M |
| Aug 18, 2026 | 6.08 | 6.275 | 6.03 | 6.19 | 1.632M |
| Aug 17, 2026 | 5.93 | 6.27 | 5.82 | 6.21 | 3.051M |
| Aug 14, 2026 | 5.90 | 6.006 | 5.716 | 5.95 | 2.132M |
| Aug 13, 2026 | 6.40 | 6.40 | 5.94 | 5.99 | 2.185M |
| Aug 12, 2026 | 6.13 | 6.449 | 6.01 | 6.405 | 3.914M |
| Aug 11, 2026 | 6.42 | 6.75 | 6.28 | 6.68 | 4.987M |
| Aug 10, 2026 | 6.48 | 6.60 | 6.218 | 6.37 | 2.240M |
| Aug 07, 2026 | 6.45 | 6.57 | 6.35 | 6.56 | 1.930M |
| Aug 06, 2026 | 6.39 | 6.55 | 6.28 | 6.34 | 2.106M |
| Aug 05, 2026 | 6.29 | 6.47 | 6.195 | 6.46 | 2.181M |
| Aug 04, 2026 | 5.88 | 6.225 | 5.775 | 6.20 | 3.702M |
| Aug 03, 2026 | 5.89 | 5.96 | 5.63 | 5.78 | 1.963M |
| Jul 31, 2026 | 5.88 | 5.92 | 5.725 | 5.86 | 2.288M |
| Jul 30, 2026 | 5.61 | 5.925 | 5.535 | 5.875 | 3.389M |
| Jul 29, 2026 | 5.41 | 5.785 | 5.33 | 5.61 | 2.700M |
| Jul 28, 2026 | 5.51 | 5.68 | 5.280 | 5.46 | 2.560M |
| Jul 27, 2026 | 5.67 | 5.98 | 5.54 | 5.54 | 2.367M |
| Jul 24, 2026 | 5.89 | 5.95 | 5.46 | 5.52 | 1.813M |
| Jul 23, 2026 | 5.505 | 5.88 | 5.47 | 5.83 | 2.442M |
| Jul 22, 2026 | 5.61 | 5.715 | 5.55 | 5.66 | 1.729M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 3.155 |
| Protalix Biotherapeutics, Inc. | 2.475 |
| Humacyte, Inc. | 0.6852 |
| Agenus, Inc. | 8.245 |
| Amgen, Inc. | 440.30 |
Price Related Metrics
| PS Ratio | 376.70 |
| PEG Ratio | -0.6597 |
| Price to Book Value | 5.053 |
| Earnings Yield | -7.19% |
| Market Cap | 1.957B |
| PEGY Ratio | -0.6597 |